*ST惠程(002168.SZ):重慶惠程未來中標重慶市璧山區中醫院一期建設項目(EPC總承包)配電安裝工程
格隆匯6月13日丨*ST惠程(002168.SZ)公佈,近日,重慶惠程信息科技股份有限公司全資子公司重慶惠程未來智能電氣有限公司(簡稱“重慶惠程未來”)中標了公司間接控股股東重慶綠髮實業集團有限公司(以下簡稱“綠髮實業集團”)的重慶市璧山區中醫院一期建設項目(EPC總承包)配電安裝工程,中標金額為4662.71萬元,重慶惠程未來擬與招標人綠髮實業集團、項目業主方重慶邁康商業管理有限公司(以下簡稱“重慶邁康”)簽署《重慶市璧山區中醫院一期建設項目(EPC總承包)配電安裝工程合同》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.